CHINA PHARMA HOLDINGS, INC. (CPHI) Insider Trading Disclosures
CHINA PHARMA HOLDINGS, INC. (CPHI) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CPHI
CIK: 1106644
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
ENROME LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerSing Hong Tan
Audit LocationSingapore, Singapore
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090173 | View SEC Doc Filr Page |
| 424B5 | 2026-07-23 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-080581 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-22 | CURRENT REPORT | 0001213900-26-080475 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057705 | View SEC Doc Filr Page |
| 10-K | 2026-04-01 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-038521 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-038495 | View SEC Doc Filr Page |
| 8-K | 2026-03-03 | 2026-02-26 | CURRENT REPORT | 0001213900-26-023022 | View SEC Doc Filr Page |
| 8-K | 2026-02-10 | 2026-02-05 | CURRENT REPORT | 0001213900-26-014338 | View SEC Doc Filr Page |
| 8-K | 2026-01-06 | 2025-12-30 | CURRENT REPORT | 0001213900-26-001785 | View SEC Doc Filr Page |
| 8-K | 2025-12-23 | 2025-12-22 | FORM 8-K | 0001213900-25-125299 | View SEC Doc Filr Page |
| 8-K | 2025-12-10 | 2025-12-04 | CURRENT REPORT | 0001213900-25-120129 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-14 | 2025-12-30 | DEFINITIVE PROXY STATEMENT | 0001213900-25-110882 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-109203 | View SEC Doc Filr Page |
| PRE 14A | 2025-11-04 | 2025-11-04 | PRELIMINARY PROXY STATEMENT | 0001213900-25-106092 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | QUARTERLY REPORT | 0001213900-25-076642 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | QUARTERLY REPORT | 0001213900-25-043334 | View SEC Doc Filr Page |
| 8-K | 2025-04-04 | 2025-04-04 | CURRENT REPORT | 0001213900-25-029000 | View SEC Doc Filr Page |
| 10-K | 2025-03-31 | 2024-12-31 | ANNUAL REPORT | 0001213900-25-026280 | View SEC Doc Filr Page |
| 8-K | 2024-12-26 | 2024-12-23 | CURRENT REPORT | 0001213900-24-112685 | View SEC Doc Filr Page |
| 8-K | 2024-12-26 | 2024-12-22 | CURRENT REPORT | 0001213900-24-112658 | View SEC Doc Filr Page |
| 8-K | 2024-12-13 | 2024-12-12 | CURRENT REPORT | 0001213900-24-108617 | View SEC Doc Filr Page |
| 424B5 | 2024-12-13 | — | PROSPECTUS SUPPLEMENT | 0001213900-24-108616 | View SEC Doc Filr Page |
| 10-Q | 2024-11-13 | 2024-09-30 | QUARTERLY REPORT | 0001213900-24-097461 | View SEC Doc Filr Page |
| DEF 14A | 2024-11-12 | 2024-12-22 | DEFINITIVE PROXY STATEMENT | 0001213900-24-096780 | View SEC Doc Filr Page |
| PRE 14A | 2024-11-01 | 2024-11-01 | PRELIMINARY PROXY STATEMENT | 0001213900-24-093490 | View SEC Doc Filr Page |